Results 11 to 20 of about 104 (87)

Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2023
Evaluation and monitoring of pemphigus vulgaris (PV) typically involve autoantibody detection by enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence (IIF).
Hossein Mortazavi   +8 more
doaj   +1 more source

Autoantibodies other than anti-desmogleins in pemphigus vulgaris patients

open access: yesIndian Journal of Dermatology, 2017
Background: Pemphigus vulgaris (PV) is an immunoglobulin G-mediated autoimmune bullous skin disease. Nonorgan-specific antibodies were detected in Tunisian and Brazilian pemphigus patients with different prevalence.
Marwah Adly Saleh   +2 more
doaj   +1 more source

Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?

open access: yesCells, 2022
Pemphigus vulgaris is an autoimmune blistering disease of the epidermis, caused by autoantibodies against desmosomal proteins, mainly desmogleins 1 and 3, which induce an impairment of desmosomal adhesion and blister formation. Recent findings have shown
Anna Zakrzewicz   +10 more
doaj   +1 more source

Recurrence of Pemphigus Vulgaris after Bilateral Breast Irradiation: A Case Report and Review of the Literature

open access: yesCase Reports in Oncology, 2021
Pemphigus is a serious and rare chronic bullous autoimmune disease. It is characterized by mucocutaneous erosions secondary to autoantibodies directed against desmogleins 1 and 3, proteins involved in intercellular adhesion mechanisms.
Camille Invernizzi   +5 more
doaj   +1 more source

Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2019
: Paraneoplastic pemphigus is a rare and severe autoimmune blistering disease characterized by mucocutaneous lesions associated with benign and malignant neoplasms.
Celina Wakisaka Maruta   +5 more
doaj   +1 more source

Taiwanese dermatological association (TDA) consensus for the management of pemphigus

open access: yesJournal of the Formosan Medical Association, 2023
Pemphigus is an uncommon but life-threatening autoimmune blistering disease characterized by the presence of antibodies against desmogleins. Without effective treatment, pemphigus can result in significant morbidity and mortality.
Chia-Yu Chu   +7 more
doaj   +1 more source

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer

open access: yesBMC Cancer, 2008
Background In a previous report we have demonstrated that the chymotryptic-like serine protease kallikrein 7 (KLK7/hK7) is overexpressed in pancreatic cancer.
Haun Randy S   +2 more
doaj   +1 more source

Autoimmune pemphigus: difficulties in diagnosis and the molecular mechanisms underlying the disease

open access: yesFrontiers in Immunology
Recently recognised as a desmosomal disorder, autoimmune pemphigus remains severe in some of its forms, such as pemphigus vulgaris. This review is divided into four parts.
Olga Simionescu, Sorin Ioan Tudorache
doaj   +1 more source

Significado do epitope spreading na patogênese dos pênfigos vulgar e foliáceo Significance of epitope spreading in the pathogenesis of pemphigus vulgaris and foliaceus

open access: yesAnais Brasileiros de Dermatologia, 2008
Os pênfigos são dermatoses bolhosas auto-imunes, em que há a produção de auto-anticorpos direcionados contra moléculas de adesão dos epitélios, levando à perda da coesão celular.
Valéria Aoki   +4 more
doaj   +1 more source

Pemphigus—A Disease of Desmosome Dysfunction Caused by Multiple Mechanisms

open access: yesFrontiers in Immunology, 2018
Pemphigus is a severe autoimmune-blistering disease of the skin and mucous membranes caused by autoantibodies reducing desmosomal adhesion between epithelial cells.
Volker Spindler, Jens Waschke
doaj   +1 more source

Home - About - Disclaimer - Privacy